SPP1 and hepatocellular carcinoma: Similarly, fibroblast-derived SPP1 was found to contribute to resistance of hepatocellular carcinoma to sorafenib and lenvatinib treatment [34], and in oral squamous cell carcinoma, the SPP1-integrin αvβ3 axis was found to be crucial for 5-fluorouracil resistance [35].